Core Viewpoint - The Shanghai Consumer Protection Committee has raised concerns regarding the authenticity of Antarctic krill oil products sold by Beijing Tongrentang (Sichuan) Health Pharmaceutical Co., Ltd., following an investigation that revealed potential false advertising and consumer rights violations [1][4]. Group 1: Company Actions and Responses - The Shanghai Consumer Protection Committee held discussions with both the distributor, Beijing Tongrentang (Sichuan) Health Pharmaceutical Co., Ltd., and the manufacturer, Anhui Hab Pharmaceutical Co., Ltd., regarding the issues with the Antarctic krill oil products [1]. - Anhui Hab Pharmaceutical Co., Ltd. admitted that the product did not contain the claimed "Antarctic krill oil" during production, while the distributor denied knowledge of any fraudulent activities [1][4]. - The Shanghai Consumer Protection Committee has urged the distributor to conduct a self-examination, inform consumers accurately, apologize for the infringement of consumer rights, and collaborate with the manufacturer to recall the problematic products [4]. Group 2: Product Pricing and Market Presence - A bottle of "Beijing Tongrentang 99% High Purity Antarctic Krill Oil" was found on e-commerce platforms priced as low as a few yuan, with one product listed at 7.5 yuan for 60 capsules [3]. - Some related Antarctic krill oil products have been removed from certain e-commerce platforms, while others remain available for sale [3]. Group 3: Legal and Ethical Implications - The Shanghai Consumer Protection Committee's investigation suggests that the involved companies may have engaged in deliberate deception, violating consumer rights and market integrity principles [4]. - Legal experts have indicated that the low procurement price of the products raises concerns about quality issues, linking the problems to the low pricing strategy [4]. - There is ongoing legal ambiguity regarding trademark infringement claims made by Beijing Tongrentang Group against its subsidiary, with potential implications for the use of the "Beijing Tongrentang" name by the subsidiary [4].

Core Viewpoint - The Shanghai Consumer Rights Protection Committee has identified a product labeled as "99% high-purity Antarctic krill oil" from Beijing Tongrentang (Sichuan) Health Pharmaceutical Co., Ltd. that falsely claims a phospholipid content of 43%, with actual tests showing a result of 0 [1][5]. Group 1: Company Involvement - Anhui Habao Pharmaceutical Co., Ltd. stated that the product in question was custom-ordered by Beijing Tongrentang (Sichuan) Health Pharmaceutical Co., Ltd., which set a procurement price significantly below normal levels [4]. - The production process did not include the claimed "Antarctic krill oil," and the distributor denied knowledge of any fraudulent activities related to the product [4][5]. - Beijing Tongrentang has initiated legal proceedings against the involved companies and has ordered the cessation of sales of the disputed product [6]. Group 2: Regulatory Actions - The Shanghai Consumer Rights Protection Committee has accused the involved companies of intentional fraud, violating consumer rights and market integrity principles [5]. - The committee has urged the distributor to conduct a self-examination, apologize to consumers, and recall the problematic products for refunds or exchanges [5]. - The committee has also notified relevant regulatory authorities in Sichuan to monitor the situation [5].

Core Insights - The event focused on women's health and emotional release, aiming to empower women to reclaim their lives and practice self-care through traditional Chinese medicine [1][4] - The initiative is part of a broader trend where over 50% of women will prioritize health and fitness spending by 2025, reflecting a growing demand for emotional stability and life control [4] Group 1: Event Overview - A two-day offline interactive event took place in Chengdu, featuring the company's classic health product, Tong Ren Tang Black-Bone Chicken Pills, in collaboration with JD Health [1] - The event's theme, "忍不住翻脸了", aimed to break traditional boundaries of Chinese medicine brand communication and connect with women's emotional experiences [1][4] Group 2: Interactive Experience - The event included immersive experiences designed to address five core life challenges faced by women: menstrual discomfort, workplace exhaustion, postpartum weakness, aging anxiety, and ovarian health [8] - Participants engaged in a unique activity where they tore down parts of giant advertisements, symbolizing their rejection of negative life experiences, and received customized health advice through professional consultations [8] Group 3: Online and Offline Integration - The event successfully created a dual-topic communication system, combining official brand messaging with user-generated content (UGC) to resonate with a broader audience [10][13] - Social media platforms like Weibo and Xiaohongshu were utilized to amplify discussions around women's collective emotional release and self-care, enhancing brand visibility and user engagement [13][15] Group 4: Brand Strategy and Consumer Engagement - The company established a dedicated online space on JD Health for users to access event-related content and promotions, including a discount offer of 30 yuan for every 200 yuan spent [15] - This approach reflects the company's exploration of integrating traditional branding with digital channels, effectively converting brand awareness into sales while providing tangible health solutions [15]

昨天（12月15日）下午，北京同仁堂（600085）健康药业股份有限公司（以下简称"北京同仁堂"）针对标称为"北京同仁堂99%高纯 南极磷虾油"的产品磷脂含量实测为0一事发布相关声明。 对于该情况，上海消保委认为相关企业涉嫌造假行为，并将于近日约谈该产品的生产企业哈博药业和经销商四川健康药业。 对此，南都·湾财社记者曾于12月11日致电上述两家企业，彼时，哈博药业相关人士表示，已知晓该情况，市场监管局相关工作人员 也到公司并介入调查当中，目前还处于调查阶段，还不清楚该产品是否为公司所生产。而四川健康药业的接线人员彼时则表示并不 北京同仁堂表示，已立即责令北京同仁堂（四川）健康药业有限公司（以下简称"四川健康药业"）停止经销该产品，并对涉事产品 开展全流程核查与追溯。 北京同仁堂还表示，"这款产品未经授权擅自突出使用'北京同仁堂'字样，涉嫌违法，我们已启动司法程序，对涉事企业进行起诉， 以求维护广大消费者和企业的合法权益。" 一款"北京同仁堂"鱼油产品磷脂含量检测为0 上海消保委认为相关企业涉嫌造假行为 据了解，上海消保委于近日发布了15款不同品牌的南极磷虾油产品比较检测结果。结果显示，其中一款由安徽哈博药业有 ...

Core Insights - The event focused on women's health and emotional release, aiming to empower women to take control of their lives and practice self-care through traditional Chinese medicine products [1][2] Group 1: Brand Philosophy - The company recognizes that over 50% of women will prioritize health and fitness spending by 2025, reflecting a shift towards a desire for inner stability and life control [2] - The product is positioned not just as a health choice but as an emotional companion for women, encouraging them to shed negative aspects of life and embrace a healthier self-image [2] Group 2: Offline Interaction - The event featured immersive experiences addressing five core issues faced by women, including menstrual challenges and workplace stress, through engaging visual displays [3] - Participants could physically tear down representations of their struggles, symbolizing a break from negative life experiences, while receiving personalized health advice [3] Group 3: Online Engagement - The event sparked a widespread online discussion, creating a dual-topic communication system that combined brand messaging with user-generated content [4] - Social media platforms like Weibo and Xiaohongshu were utilized to amplify the event's reach, encouraging collective emotional release and self-care discussions among women [4] Group 4: From Resonance to Support - The company aims to provide practical health solutions and convenient purchasing paths, launching a dedicated online space for users to access products and promotions [5] - The integration of offline experiences with online sales strategies represents a deep exploration of the traditional brand and digital channel collaboration, enhancing the brand's market presence [5][6]

Group 1 - The company, Beijing Tongrentang Health Pharmaceutical Co., Ltd., has issued a statement regarding a product labeled as "99% high-purity Antarctic krill oil," which is suspected of false labeling of its ingredients [1] - The company has ordered its subsidiary, Sichuan Health Pharmaceutical Co., Ltd., to cease the distribution of the product and has initiated a full-process investigation and traceability of the involved product [1] - The product was unauthorizedly using the "Beijing Tongrentang" name, leading the company to initiate legal proceedings against the involved enterprises to protect consumer rights and the company's interests [1] Group 2 - The Shanghai Consumer Protection Commission reported that a recent investigation into 15 popular Antarctic krill oil products revealed that the product in question claimed a phospholipid content of 43%, but the actual measured value was 0% [4] - The Shanghai Consumer Protection Commission plans to interview the production company, Anhui Habao Pharmaceutical Co., Ltd., and the distributor, Sichuan Health Pharmaceutical Co., Ltd., to demand explanations regarding the product's actual content [4]

转自：北京日报客户端 同仁堂知嘛健康零号店成立于 2019年，是同仁堂落实老字号传承创新发展要求、探索大健康产业升级 新零售模式而开办的健康产品体验店。店内面积约 4700平方米，共 3层，拥有数十个参观场景。多年 来，知嘛健康零号店有效发挥了老字号品牌创新发展的窗口作用，充分展示了中医药文化和老字号企业 的文化自信。 运营模式 现场教学通过参观体验展销售卖、养生产品品鉴、手工DIY、中医问诊等多个场景，沉浸式了解老字号 企业在中医药健康养生领域传承创新的产品成果，感知老字号新国潮魅力。 零号店作为同仁堂健康打造的新零售超级概念店，横跨象、食、养、医四大产品与服务，覆盖多元化购 物休闲场景，打通线上线下场景消费的一站式健康生活体验馆。 零号店采用线下、线上互联互通的OMO创新运营模式，将线下体验与线上商品售卖相结合，实现商品 与服务的所见即所买。同时，零号店围绕用户及其数字化服务，通过人、货、场的升级，使得会员线上 线下的全面连接成为可能。通过会员管理、健康数据追踪的一体化健康服务，为会员提供实时、精准的 24小时服务。 科技赋能 联系电话：010-81058806转1 来源：北京日报客户端 地 址：大兴区思 ...

Core Viewpoint - On December 15, Beijing Tongrentang Health Industry Co., Ltd. announced that it has ordered its subsidiary, Sichuan Tongrentang Health Industry Co., Ltd., to stop distributing the "99% High Purity Antarctic Krill Oil" product due to allegations of false labeling of its ingredients, and has initiated legal proceedings against the involved companies [1][9]. Group 1: Company Actions and Responses - The company has launched a full-process investigation and traceability for the disputed product, which was found to have falsely used the "Beijing Tongrentang" name without authorization [1][9]. - The Shanghai Consumer Protection Commission has announced plans to interview the production company, Anhui Habao Pharmaceutical Co., Ltd., and the distributor, Sichuan Tongrentang Health Industry, to clarify the product's actual situation [9]. - The company has advised consumers to purchase "Beijing Tongrentang" products only through official channels and to recognize the "Double Dragon" trademark to avoid potential losses [9]. Group 2: Brand and Market Context - The Tongrentang brand has faced multiple disputes regarding authenticity, including trademark infringement cases involving three recognized Tongrentang brands: Beijing Tongrentang, Tianjin Tongrentang, and Nanjing Tongrentang [10][11]. - The internal structure of Tongrentang Group is complex, with three listed companies under its umbrella, and it has been involved in previous controversies, such as the 2018 case where a subsidiary was fined over 14 million yuan for using expired honey [6][10]. - Despite efforts to unify the three Tongrentang brands, the ownership structure remains fragmented, with Beijing Tongrentang Group controlled by the Beijing State-owned Assets Supervision and Administration Commission, while Nanjing Tongrentang is controlled by the Qingdao State-owned Assets Supervision and Administration Commission [11].

Core Viewpoint - Beijing Tongrentang has initiated legal proceedings against its subsidiary, Beijing Tongrentang (Sichuan) Health Pharmaceutical Co., Ltd., due to allegations of false labeling on a product marketed as "99% high-purity Antarctic krill oil" [1][2]. Group 1: Company Actions - Beijing Tongrentang has ordered its subsidiary to cease the distribution of the implicated product and is conducting a full process review and traceability investigation [1]. - The company claims that the product was marketed without authorization, violating legal standards, and has taken steps to protect consumer rights through legal action [2]. Group 2: Product Allegations - The product in question was reported to have misleading claims, including high phospholipid content, but testing revealed a phospholipid content of 0% [1]. - The Shanghai Consumer Protection Committee plans to interview the manufacturers and distributors involved to clarify the product's actual composition [2]. Group 3: Ownership Structure - Beijing Tongrentang (Sichuan) Health Pharmaceutical Co., Ltd. is 51% owned by Beijing Tongrentang, with the remaining shares held by individual shareholders [4].

Policy Developments - The National Medical Insurance Administration has issued a three-year action plan to enhance the efficiency of medical insurance fund settlement, aiming to complete annual settlements by March 31 each year starting in 2028, with settlement funds accounting for about 3% of the annual medical insurance fund allocation [2] Medical Device Approvals - Jiukang Bio has received a medical device registration certificate for its fructosamine testing kit, which is expected to enhance its product line in the in vitro diagnostic sector [5] - Yihuilong has obtained registration for its anti-phosphatidylserine/prothrombin IgM and IgG antibody testing kits, which will expand its automated chemiluminescence product line [6] - Kangzheng Pharmaceutical's oral JAK1 inhibitor, Povorcitinib, has been included in the "Breakthrough Therapy" list for treating non-segmental vitiligo in adults [7] Capital Market Activities - Fosun Pharma plans to invest a total of 1.412 billion yuan in Green Valley Pharmaceutical, acquiring a 53% stake through its subsidiary [9] - Paig Bio-Medical has announced a further extension of the lock-up period for cornerstone investors until April 30, 2026, and is raising approximately 296 million HKD for various strategic initiatives [10][11] Industry Developments - Nanjing has established a medical health merger and acquisition equity investment fund with a total investment of 800 million yuan, focusing on equity investment and asset management [13] - Zhenghai Bio has signed a 12 million yuan technical development contract with the Chinese Academy of Agricultural Sciences for the research and development of recombinant type III collagen products [14] - MicroPort Robotics has established a new medical technology company with a registered capital of 15 million yuan, focusing on the development and manufacturing of service robots [15] Public Opinion Alerts - Tongrentang has responded to allegations of false labeling regarding its Antarctic krill oil product, initiating legal action against the involved parties to protect consumer rights [17]